Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT05600088Not ApplicableActive Not Recruiting

Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With (N)STEMI or Unstable Angina

Role: collaborator

NCT05253677Not ApplicableActive Not Recruiting

Precise Procedural and PCI Plan (P4)

Role: lead

NCT05810051Not ApplicableActive Not Recruiting

Exercise and Coronary Microvascular Disease

Role: lead

NCT06205810Recruiting

The COMPLETE Study

Role: lead

NCT06898021Recruiting

The 3D Stent Study

Role: lead

NCT05805462Active Not Recruiting

The Euro-CRAFT Registry

Role: lead

NCT05437900Phase 4Recruiting

INSIGHTFUL-FFR Clinical Trial

Role: lead

NCT06939374Not ApplicableNot Yet Recruiting

Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With Stable Angina or ACS - A Traditional Feasibility Study

Role: collaborator

NCT06854302Enrolling By Invitation

Angina After PCI: a Systems Medicine Study

Role: collaborator

NCT06159231Completed

FAME II-10-year Follow-Up

Role: lead

All 10 trials loaded